SMT202000288T1 - Formulazione farmaceutica comprendente inositolo - Google Patents

Formulazione farmaceutica comprendente inositolo

Info

Publication number: SMT202000288T1
Authority: SM; San Marino
Prior art keywords: pharmaceutical formulation; formulation including; including inositol; inositol; pharmaceutical
Prior art date: 2011-03-22

Application number

SM20200288T

Other languages

English (en)

Inventor

Vittorio Unfer

Original Assignee

Lo Li Pharma Srl

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-03-22

Filing date

2012-03-22

Publication date

2020-07-08

2012-03-22 Application filed by Lo Li Pharma Srl filed Critical Lo Li Pharma Srl

2020-07-08 Publication of SMT202000288T1 publication Critical patent/SMT202000288T1/it

Links

SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 title 1
CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 title 1
229960000367 inositol Drugs 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1
CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5052—Proteins, e.g. albumin
- A61K9/5057—Gelatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Diabetes (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Obesity (AREA)
Molecular Biology (AREA)
Hematology (AREA)
Emergency Medicine (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pregnancy & Childbirth (AREA)
Gynecology & Obstetrics (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

SM20200288T 2011-03-22 2012-03-22 Formulazione farmaceutica comprendente inositolo SMT202000288T1 (it)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IT000445A ITMI20110445A1 (it)	2011-03-22	2011-03-22	Formulazione farmaceutica comprendente inositolo.
EP16202982.1A EP3178474B1 (en)	2011-03-22	2012-03-22	Pharmaceutical formulation comprising inositol

Publications (1)

Publication Number	Publication Date
SMT202000288T1 true SMT202000288T1 (it)	2020-07-08

Family

ID=43977111

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
SM20200288T SMT202000288T1 (it)	2011-03-22	2012-03-22	Formulazione farmaceutica comprendente inositolo
SM20200364T SMT202000364T1 (it)	2011-03-22	2012-03-22	Formulazione farmaceutica comprendente inositolo

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
SM20200364T SMT202000364T1 (it)	2011-03-22	2012-03-22	Formulazione farmaceutica comprendente inositolo

Country Status (23)

Country	Link
US (1)	US20140010870A1 (it)
EP (2)	EP3178474B1 (it)
CL (1)	CL2013002700A1 (it)
CY (2)	CY1122980T1 (it)
DK (2)	DK2502622T3 (it)
EA (1)	EA026746B1 (it)
ES (2)	ES2798267T3 (it)
HR (2)	HRP20200792T1 (it)
HU (2)	HUE049942T2 (it)
IL (1)	IL228465B (it)
IT (1)	ITMI20110445A1 (it)
LT (2)	LT3178474T (it)
MA (1)	MA35043B1 (it)
ME (1)	ME03750B (it)
MX (1)	MX2013010812A (it)
PE (1)	PE20141011A1 (it)
PL (2)	PL3178474T3 (it)
PT (2)	PT3178474T (it)
RS (2)	RS60377B1 (it)
SM (2)	SMT202000288T1 (it)
TN (1)	TN2013000373A1 (it)
UA (1)	UA115425C2 (it)
WO (1)	WO2012126931A1 (it)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ITUA20163025A1 (it)	2016-04-29	2017-10-29	Sochim Int S P A	Composizione per il trattamento della sindrome dell’ovaio policistico
US11040016B2 (en) *	2016-10-06	2021-06-22	Dy Natural Co., Ltd	Composition for alleviating, preventing or treating female menopausal symptoms, containing, as active ingredient, pinitol, D-chiro-inositol or analog compounds thereof
US11898184B2 (en)	2017-09-07	2024-02-13	Sweet Sense Inc.	Low glycemic sugar composition
EP3713552A1 (en) *	2017-11-23	2020-09-30	Biosearch S.A.	Method for increasing embryo implantation rate in a female subject suffering polycystic ovary syndrome
MX2021001966A (es) *	2018-08-22	2021-05-12	Nestle Sa	Composicion que comprende isomeros de inositol y su uso.
WO2021038035A1 (en) *	2019-08-30	2021-03-04	Société des Produits Nestlé S.A.	Scyllo-inositol and b-cell mediated disorders
CN115484939A (zh) *	2019-09-24	2022-12-16	雀巢产品有限公司	鲨肌醇及其作为胰岛素敏化剂的用途
RU2757220C1 (ru) *	2020-06-03	2021-10-12	Общество с ограниченной ответственностью "ОКТАВА ХОЛДИНГ"	Фармацевтическая композиция для профилактики и лечения синдрома поликистозных яичников
RU2771426C1 (ru) *	2021-05-03	2022-05-04	Румиса Рамзановна Бериханова	Способ коррекции дислипидемии у женщин с метаболическим синдромом в периоде менопаузального перехода
IT202300017805A1 (it) *	2023-08-30	2025-03-02	Idi Integratori Dietetici Italiani S R L	Nuova composizione comprendente teupolioside e inositolo
WO2025254861A1 (en) *	2024-06-04	2025-12-11	Eirgen Pharma, Ltd.	A combination of scyllo-inositol and n-acetyl cysteine and related compounds
GR1011145B (el) *	2025-03-24	2026-03-04	Ιουλια Τσετη	Συνθεση μυοϊνοσιτολης για υποστηριξη γυναικων με συνδρομο πολυκυστικων ωοθηκων υπο μορφη μονοδοσικου ποσιμου διαλυματος
GR1011018B (el) *	2024-07-10	2025-08-27	Ιουλια Τσετη	Συνθεση για υποστηριξη γυναικων με συνδρομο πολυκυστικων ωοθηκων
WO2026013420A1 (en)	2024-07-10	2026-01-15	Ioulia Tseti	Compositions for supporting women with gynaecological syndromes

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8305693D0 (en) *	1983-03-02	1983-04-07	Scherer Ltd R P	Pharmaceutical compositions
JPH04504847A (ja) *	1989-03-08	1992-08-27	ザ　ユニバーシティ　オヴ　バージニア　パテント　ファウンデーション	インスリン抵抗性糖尿病のための食事用補添物
TW282398B (it) *	1993-12-22	1996-08-01	Bristol Myers Squibb Co
BR0010014A (pt) *	1999-04-27	2002-01-15	Insmed Pharm Inc	Composição farmacêutica compreendendo um inositol e um ìon de metal para melhorar sensibilidade à insulina e metabolismo de glucose
JP4361710B2 (ja) *	2000-04-19	2009-11-11	ジェネンテック・インコーポレーテッド	徐放製剤
AU2005265617B2 (en) *	2004-07-30	2010-09-30	Wakunaga Pharmaceutical Co., Ltd.	Composition for capsule film, capsule film, and capsule made with the same
US20090149481A1 (en) *	2005-07-04	2009-06-11	Tokyo Medical And Dental University	Pharmaceutical composition and beverage composition comprising l-arginine
US20070243211A1 (en) *	2005-11-07	2007-10-18	Jaffe Russell M	Compositions for regulating metabolic disorders and methods of use thereof
US20070104801A1 (en) *	2005-11-07	2007-05-10	Ivf Online Llc	Fertility and anti-aging supplement for the fertility health of females and males
ITRM20070341A1 (it) *	2007-06-20	2008-12-21	Lo Li Pharma Srl	Formulazione integrativa inofolic finalizzata al controllo dell'induzione dell'ovulazione in programmi di procreazione medicalmente assistita
WO2011112167A1 (en) *	2009-03-13	2011-09-15	Reset Therapeutics, Inc.	Compositions and methods for diabetes treatment
CA2791561A1 (en) *	2010-03-01	2011-09-09	Ratiopharm Gmbh	Dabigatran etexilate-containing oral pharmaceutical composition

2011
- 2011-03-22 IT IT000445A patent/ITMI20110445A1/it unknown
2012
- 2012-03-21 US US14/006,582 patent/US20140010870A1/en not_active Abandoned
- 2012-03-21 UA UAA201312411A patent/UA115425C2/uk unknown
- 2012-03-21 MA MA36334A patent/MA35043B1/fr unknown
- 2012-03-21 MX MX2013010812A patent/MX2013010812A/es active IP Right Grant
- 2012-03-21 WO PCT/EP2012/054960 patent/WO2012126931A1/en not_active Ceased
- 2012-03-21 EA EA201301061A patent/EA026746B1/ru not_active IP Right Cessation
- 2012-03-21 PE PE2013002088A patent/PE20141011A1/es not_active Application Discontinuation
- 2012-03-22 DK DK12160674.3T patent/DK2502622T3/da active
- 2012-03-22 RS RS20200667A patent/RS60377B1/sr unknown
- 2012-03-22 EP EP16202982.1A patent/EP3178474B1/en active Active
- 2012-03-22 LT LTEP16202982.1T patent/LT3178474T/lt unknown
- 2012-03-22 SM SM20200288T patent/SMT202000288T1/it unknown
- 2012-03-22 ME MEP-2020-118A patent/ME03750B/me unknown
- 2012-03-22 RS RS20200966A patent/RS60650B1/sr unknown
- 2012-03-22 ES ES16202982T patent/ES2798267T3/es active Active
- 2012-03-22 DK DK16202982.1T patent/DK3178474T3/da active
- 2012-03-22 PT PT162029821T patent/PT3178474T/pt unknown
- 2012-03-22 PL PL16202982T patent/PL3178474T3/pl unknown
- 2012-03-22 ES ES12160674T patent/ES2806937T3/es active Active
- 2012-03-22 PL PL12160674T patent/PL2502622T3/pl unknown
- 2012-03-22 PT PT121606743T patent/PT2502622T/pt unknown
- 2012-03-22 HU HUE16202982A patent/HUE049942T2/hu unknown
- 2012-03-22 HU HUE12160674A patent/HUE051001T2/hu unknown
- 2012-03-22 LT LTEP12160674.3T patent/LT2502622T/lt unknown
- 2012-03-22 SM SM20200364T patent/SMT202000364T1/it unknown
- 2012-03-22 EP EP12160674.3A patent/EP2502622B1/en active Active
2013
- 2013-09-16 IL IL228465A patent/IL228465B/en active IP Right Grant
- 2013-09-20 TN TNP2013000373A patent/TN2013000373A1/fr unknown
- 2013-09-23 CL CL2013002700A patent/CL2013002700A1/es unknown
2020
- 2020-05-15 HR HRP20200792TT patent/HRP20200792T1/hr unknown
- 2020-06-02 CY CY20201100518T patent/CY1122980T1/el unknown
- 2020-07-02 HR HRP20201048TT patent/HRP20201048T1/hr unknown
- 2020-07-20 CY CY20201100657T patent/CY1123134T1/el unknown

Also Published As

Publication number	Publication date
ME03750B (me)	2021-04-20
ES2806937T3 (es)	2021-02-19
HRP20200792T1 (hr)	2020-07-24
EP3178474A1 (en)	2017-06-14
HRP20201048T1 (hr)	2020-10-16
ITMI20110445A1 (it)	2012-09-23
RS60650B1 (sr)	2020-09-30
US20140010870A1 (en)	2014-01-09
PT2502622T (pt)	2020-06-29
PL2502622T3 (pl)	2020-11-16
WO2012126931A1 (en)	2012-09-27
UA115425C2 (uk)	2017-11-10
CY1122980T1 (el)	2021-10-29
MX2013010812A (es)	2014-03-21
LT3178474T (lt)	2020-05-11
RS60377B1 (sr)	2020-07-31
CL2013002700A1 (es)	2014-07-11
PT3178474T (pt)	2020-05-06
EP3178474B1 (en)	2020-03-18
EA026746B1 (ru)	2017-05-31
PE20141011A1 (es)	2014-08-27
EP2502622A1 (en)	2012-09-26
HUE051001T2 (hu)	2021-01-28
MA35043B1 (fr)	2014-04-03
EA201301061A1 (ru)	2014-02-28
HUE049942T2 (hu)	2020-11-30
LT2502622T (lt)	2020-07-27
CY1123134T1 (el)	2021-10-29
IL228465B (en)	2018-01-31
DK2502622T3 (da)	2020-09-07
SMT202000364T1 (it)	2020-09-10
EP2502622B1 (en)	2020-06-10
ES2798267T3 (es)	2020-12-10
DK3178474T3 (da)	2020-06-08
PL3178474T3 (pl)	2020-09-21
TN2013000373A1 (en)	2015-01-20
IL228465A0 (en)	2013-12-31

Publication	Publication Date	Title
CO6852076A2 (es)	2014-01-30	Composiciones farmacéuticas inhalables
BR112014003052A2 (pt)	2017-03-01	composições farmacêuticas
DK2694038T3 (da)	2019-08-19	Farmaceutisk sammensætning
DK3181128T3 (da)	2023-06-06	Farmaceutisk nilotinib-sammensætning
DK2502622T3 (da)	2020-09-07	Farmaceutisk formulering omfattende inositol
HUE056014T2 (hu)	2022-01-28	Lipidek gyógyszerszállító készítményekhez
CO6930367A2 (es)	2014-04-28	Composiciones farmaceúticas
CO6940426A2 (es)	2014-05-09	Formulaciones farmacéuticas
BR112014000015A2 (pt)	2017-02-07	formulação
DK2897594T3 (da)	2020-06-29	Farmaceutisk sammensætning
DK2868318T4 (da)	2022-03-28	Injicerbar formulering
BR112014015885A2 (pt)	2017-06-13	preparação farmacêutica
HUE039907T2 (hu)	2019-02-28	Gyógyszer-szállító technológia
BR112014009319A2 (pt)	2017-05-30	compostos farmacêuticos
EP2769718A4 (en)	2015-07-01	MEDICAL COMPOSITION
DK2877155T3 (da)	2021-01-18	Opioidformuleringer
EP2770828A4 (en)	2015-04-15	FORMULATION
EP2794550A4 (en)	2015-10-21	OPHTHALMIC FORMULATION
DK3473255T3 (da)	2022-04-04	Farmaceutisk formulering omfattende ciclesonid
BR112015002646A2 (pt)	2018-02-06	composto e composição farmacêutica
EP2773204A4 (en)	2015-05-27	Pazopanib FORMULATION
BR112013033052A2 (pt)	2017-07-04	formulações de entrega de fármaco
PL2638894T3 (pl)	2017-02-28	Kompozycja farmaceutyczna z fosfolipidem
EP2687212A4 (en)	2015-10-14	DRUG
PL2908836T3 (pl)	2020-06-15	Formulacja farmaceutyczna zawierająca kurkuminę